Bottom line
Is EVIBX a good fund? The bottom line
EVIBX is a share class of Eaton Vance Income Fund of Boston, an actively managed core / intermediate bond mutual fund from Morgan Stanley.
Its expense ratio is 0.96% — about $96 a year on every $10,000 invested, more expensive than 69% of core / intermediate bond funds we track.
It returned +4.8% over one year, +3.9% a year over five years, +5.3% a year over ten (as of Dec 31, 2025, per its prospectus).
With $3.9 billion in net assets and 428 holdings, its largest position is Morgan Stanley & Co. LLC (2.2%) and the top 10 make up 10.4% of the portfolio.
This share class carries a front-end sales charge of up to 3.25%; a no-load class or ETF alternative can avoid it.
What stands out
- 5-year return beat 77% of category peers
- Broadly diversified (428 holdings)
What to watch
- Front-end sales load up to 3.25%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What EVIBX invests in
The Funds investment objective is to provide a high level of current income. The Funds secondary objectives are to seek growth of income and capital.
The Fund currently invests primarily in high yield, high risk corporate bonds (commonly referred to as junk bonds) which are rated lower than investment grade (i.e., bonds rated lower than Baa by Moodys Investors Service, Inc. (Moodys) or lower than BBB by S&P Global Ratings (S&P) or Fitch Ratings (Fitch)) or are unrated and of comparable quality as determined by the investment adviser. Bonds rated BBB and Baa have speculative characteristics, while lower rated bonds are predominantly speculative. The Fund may hold securities that are unrated or in the lowest rating categories (rated ?C by Moodys or D by S&P or Fitch). Bonds rated C by Moodys are regarded as having extremely poor prospects of ever attaining any real investment standing. Bonds rated D by S&P or Fitch are in payment default or a bankruptcy petition has been filed and debt service payments are jeopardized. The Fund may…
From the fund's prospectus (filed Feb 26, 2026).
EVIBX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| EVIBX | +4.8% | +3.9% | +5.3% |
| Core / Intermediate Bond median | +7.2% | +1.4% | +3.0% |
Source: Fund prospectus, as of Dec 31, 2025
What EVIBX costs
On a $10,000 investment, EVIBX's 0.96% expense ratio costs about $96 a year. The prospectus estimates $1,465 in total costs over 10 years (assuming 5% annual returns). The median core / intermediate bond fund charges 0.71%.
EVIBX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Morgan Stanley & Co. LLC | 2.19% |
| 2 | Beach Acquisition Bidco | 1.50% |
| 3 | ABC Technologies Inc | 1.01% |
| 4 | Cloud Software Grp Llc | 0.99% |
| 5 | Sunoco Lp | 0.86% |
| 6 | Medline Borrower Lp | 0.85% |
| 7 | Athenahealth Group Inc | 0.84% |
| 8 | Olympus Wtr US Hldg Corp | 0.73% |
| 9 | Bausch Health Companies Inc | 0.72% |
| 10 | Oak-eagle Acquireco Inc | 0.68% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 10.4% of the fund. See all top 25 holdings and asset mix →